ECS Botanics Valuation
| ECS Stock | 0.02 0 6.25% |
ECS Botanics seems to be overvalued based on Macroaxis valuation methodology. Our model computes the value of ECS Botanics Holdings from examining the entity fundamentals such as Current Valuation of 18.23 M, return on asset of 0.0397, and Profit Margin of 0.1 % as well as evaluating its technical indicators and probability of bankruptcy.
Price Book 0.781 | Enterprise Value 18.2 M | Enterprise Value Ebitda 5.6477 | Price Sales 1.1 | Enterprise Value Revenue 0.9102 |
Overvalued
Today
Please note that ECS Botanics' price fluctuation is out of control at this time. Calculation of the real value of ECS Botanics Holdings is based on 3 months time horizon. Increasing ECS Botanics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
ECS Botanics' intrinsic value may or may not be the same as its current market price of 0.02, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.017 | Real 0.0151 | Hype 0.02 |
The intrinsic value of ECS Botanics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence ECS Botanics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of ECS Botanics Holdings helps investors to forecast how ECS stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ECS Botanics more accurately as focusing exclusively on ECS Botanics' fundamentals will not take into account other important factors: ECS Botanics Cash |
|
ECS Botanics Total Value Analysis
ECS Botanics Holdings is currently projected to have takeover price of 18.23 M with market capitalization of 22.03 M, debt of 1.02 M, and cash on hands of 1.87 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the ECS Botanics fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
18.23 M | 22.03 M | 1.02 M | 1.87 M |
ECS Botanics Investor Information
About 37.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.78. Some equities with similar Price to Book (P/B) outperform the market in the long run. ECS Botanics Holdings had not issued any dividends in recent years. The entity had 1:15 split on the 26th of November 2024. Based on the key indicators related to ECS Botanics' liquidity, profitability, solvency, and operating efficiency, ECS Botanics Holdings is performing exceptionally good at this time. It has a great probability to report excellent financial results in January.ECS Botanics Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. ECS Botanics has an asset utilization ratio of 60.92 percent. This implies that the Company is making USD0.61 for each dollar of assets. An increasing asset utilization means that ECS Botanics Holdings is more efficient with each dollar of assets it utilizes for everyday operations.ECS Botanics Ownership Allocation
ECS Botanics holds a total of 1.3 Billion outstanding shares. ECS Botanics Holdings retains substantial amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the entity is less than the current market value, you may not be able to make money on it.ECS Botanics Profitability Analysis
The company reported the revenue of 20.03 M. Net Income was 1.92 M with profit before overhead, payroll, taxes, and interest of 5.31 M.About ECS Botanics Valuation
The stock valuation mechanism determines ECS Botanics' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of ECS Botanics Holdings based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of ECS Botanics. We calculate exposure to ECS Botanics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ECS Botanics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 7.5 M | 3.9 M |
Additional Tools for ECS Stock Analysis
When running ECS Botanics' price analysis, check to measure ECS Botanics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ECS Botanics is operating at the current time. Most of ECS Botanics' value examination focuses on studying past and present price action to predict the probability of ECS Botanics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ECS Botanics' price. Additionally, you may evaluate how the addition of ECS Botanics to your portfolios can decrease your overall portfolio volatility.